Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver

Table 9 Analysis of cytokine results in the two groups

Immunity	DILI (n = 31)	DILI + NAFL (n = 39)	P value
Interferon (pg/mL)	1.46 (0.67, 3.43)	2.29 (1.58, 3.14)	0.149
Tumor necrosis factor (pg/mL)	0.86 (0.48, 1.48)	1.09 (0.62, 2.27)	0.163
IL-2 (pg/mL)	0 (0, 0.93)	0.4 (0, 2.56)	0.092
IL-4 (pg/mL)	0.56 (0.28, 1.69)	1.6 (0.82, 2.69)	0.007
IL-6 (pg/mL)	4.65 (1.82, 6.39)	5.11 (2.79, 9.54)	0.144
IL-10 (pg/mL)	4.16 (2.85, 11.95)	4.28 (2.22, 9.91)	0.92
IL-17 (pg/mL)	0.91 (0.38, 1.95)	1.1 (0.6, 2.35)	0.274

DILI: Drug-induced liver injury; NAFL: Nonalcoholic fatty liver; IL: Interleukin.